ReviewWorld journal of microbiology & biotechnology2022
Roles of LuxR-family regulators in the biosynthesis of secondary metabolites in Actinobacteria.
Review in World journal of microbiology & biotechnology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed, 12 citations in OpenAlex.
- Salt-induced 7-deoxypactamycin and oligomycin production in Streptomyces sp. strain TUA-HK1GM isolated from kusaya gravy.The Journal of antibiotics · 2026Article
- Optimized production of concanamycins using a rational metabolic engineering strategy.Metabolic engineering · 2025Article
- Positive regulation of a LuxR family protein, MilO, in mildiomycin biosynthesis.Applied and environmental microbiology · 2025Article
- Assessing the Impact of Bedaquiline, Clofazimine, and Linezolid on Mycobacterial Genome Integrity.Biomolecules · 2024Article
- Mutagenetic analysis of the biosynthetic pathway of tetramate bripiodionen bearing 3-(2H-pyran-2-ylidene)pyrrolidine-2,4-dione skeleton.Microbial cell factories · 2024Article
- The roles of SARP family regulators involved in secondary metabolism inFrontiers in microbiology · 2024Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 1 institution in 1 country.
Funding
Abstract
Actinobacteria are well-known Gram-positive bacteria that produce approximately two-thirds of microbial bioactive natural products (NPs) through secondary metabolism. Usually, genes involved in the biosynthesis of NPs in actinobacteria are clustered, and their expression is regulated by an elaborate and stringent regulatory network formed by diverse regulators. These regulators can be classified into more than 50 superfamilies/families according to conserved amino acid sequences and biological functions. Among them, LuxR family regulators, which are widely distributed in microorganisms and feature an HTH_LUXR domain (PFAM00196, SMART00421), play key roles in quorum sensing (QS), bioluminescence, virulence and secondary metabolism. In this mini-review, we focus on their roles in regulating NP production in actinobacteria. First, the domain architecture and classification of LuxR proteins are summarized on the basis of their size and biological function diversity. Second, the landscape of the roles and action mechanism of LuxR regulators involved in NP production in actinobacteria is presented in detail. Finally, the application of LuxR is described from two perspectives: enhancement of NP production and discovery of novel NPs by engineering LuxR. This mini-review will help us comprehensively understand the role of LuxR in actinobacteria and promote the future application of LuxR family regulators in synthetic biology.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.